HomeHBP • TSE
Helix Biopharma Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.55M | -14.81% |
Net income | -1.54M | 15.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.55M | 14.79% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 715.00K | 0.70% |
Total assets | 1.01M | -11.88% |
Total liabilities | 2.40M | 59.40% |
Total equity | -1.39M | — |
Shares outstanding | 53.04M | — |
Price to book | -30.00 | — |
Return on assets | -238.85% | — |
Return on capital | 551.10% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -1.54M | 15.67% |
Cash from operations | -1.38M | -22.76% |
Cash from investing | 0.00 | — |
Cash from financing | 100.00K | -94.20% |
Net change in cash | -1.28M | -317.12% |
Free cash flow | -881.25K | -98.65% |
Previous close
$0.90
Day range
$0.91 - $0.93
Year range
$0.50 - $1.35
Market cap
68.96M CAD
Avg Volume
1.40K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
Founded
1995
Headquarters
Website
Employees
7
